Comparison

Tofacitinib European Partner

Item no. M1820-50mg
Manufacturer AbMole
CASRN 477600-75-2
Amount 50mg
Category
Type Inhibitors
Specific against other
Purity 1
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias CP-690550, Tasocitinib
Similar products Tofacitinib, CP-690550, Tasocitinib
Available
Target Information
JAK
Molecular Weight
312, 37
Solubility
DMSO ≥60 mg/mL
Bioactivity information
Tofacitinib (formerly tasocitinib, CP-690550) is a novel Janus Kinase 3 (JAK-3) kinase inhibitor with an IC50 value estimated at 0.2 μM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Delivery expected until 9/4/2025 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close